iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
63 hedge funds and large institutions have $45.1M invested in iShares Genomics Immunology and Healthcare ETF in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
Holders
63
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.97M | |
| 2 | +$2.06M | |
| 3 | +$1.66M | |
| 4 |
CPG
Custom Portfolio Group
Englewood,
Colorado
|
+$725K |
| 5 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
+$465K |
Top Sellers
| 1 | -$9.32M | |
| 2 | -$2.98M | |
| 3 | -$896K | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$604K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$593K |